Risk stratification and therapy response values of 11C-PIB positron emission tomography for amyloid light-chain amyloidosis

X Wang, B Liu, C Ren, Z Huang, H Ding, H Zhang… - 2022 - Soc Nuclear Med
2294 Introduction: 11 C-PIB PET/CT has shown promise as aspecific and non-invasive
method for the diagnosis of cardiac amyloidosis (CA). The clinical risk stratification of …

Independent prognostic utility of 11C-Pittsburgh compound B PET in patients with light-chain cardiac amyloidosis

YJ Choi, Y Koh, HJ Lee, IC Hwang… - Journal of Nuclear …, 2022 - Soc Nuclear Med
11C-Pittsburgh compound B (PiB) PET/CT visualizes the amount of myocardial amyloid
deposit and can be used to prognosticate patients with amyloid light-chain (AL) cardiac …

Diagnostic Accuracy of [11C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis

S Rosengren, T Skibsted Clemmensen, L Tolbod… - Cardiovascular …, 2020 - jacc.org
Objectives This dual-site study evaluated the diagnostic accuracy of the method.
Background Pittsburgh compound ([11C] PIB) positron emission tomography (PIB-PET) has …

37 Diagnostic accuracy of [11C] PIB positron emission tomography for detection of cardiac amyloidosis

S Rosengren, T Skibsted Clemmensen… - European Heart …, 2019 - academic.oup.com
Background:[11C] PIB positron emission tomography (PIB-PET) has shown promise as a
specific and non-invasive method for the diagnosis of cardiac amyloidosis (CA). Objectives …

[HTML][HTML] Diagnostic value of 11C-PIB PET/MR in cardiac Amyloidosis

X Bi, B Xu, J Liu, G Wang, J An, X Zhang… - Frontiers in …, 2022 - frontiersin.org
Backgroud: The thioflavin T derivative, 11C-Pittsburgh-B (PIB), is used for Alzheimer's
disease imaging because it specifically binds to β-amyloid protein deposits in the brain. The …

11C-Pittsburgh B PET Imaging in Cardiac Amyloidosis

SP Lee, ES Lee, H Choi, HJ Im, Y Koh, MH Lee… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: This study sought to investigate the efficacy of 11C-Pittsburgh B (PiB) positron
emission tomography (PET)/computed tomography (CT) in the diagnosis of cardiac …

Pittsburgh B compound positron emission tomography in patients with AL cardiac amyloidosis

SP Lee, HY Suh, S Park, S Oh, SG Kwak… - Journal of the American …, 2020 - jacc.org
Background It remains unknown whether the noninvasive evaluation of the degree of
amyloid deposition in the myocardium can predict the prognosis of patients with light chain …

Characterization of 18F-Florbetapir and 68Ga-FAPI-04 PET/CT in light-chain cardiac amyloidosis

X Wang, B Liu, C Ren, Z Huang, H Ding, H Zhang… - 2023 - Soc Nuclear Med
P857 Introduction: Light chain cardiac amyloidosis (AL-CA) causes one of the mortal forms
of heart failure (HF) with worse survival. So early diagnosis, risk stratification is essential in …

Reproducibility and repeatability of assessment of myocardial light chain amyloidosis burden using 18F-florbetapir PET/CT

FS Prato, G Wisenberg - Journal of Nuclear Cardiology, 2021 - Elsevier
In this edition of the JNC, Nodoushani et al 1 have demonstrated the reproducibility and
repeatability of 18 F-florbetapir PET imaging for the assessment of AL cardiac amyloidosis …

Comparison of 18F-sodium fluoride positron emission tomography imaging and 99mTc-pyrophosphate in cardiac amyloidosis

LX Zhang, P Martineau, V Finnerty, G Giraldeau… - Journal of Nuclear …, 2022 - Elsevier
Background Pyrophosphate (PYP) scintigraphy provides high diagnostic accuracy for the
detection of transthyretin (ATTR) cardiac amyloidosis (CA). There has recently been …